Xiaowei Chang
Direttore/Membro del Consiglio presso AMBRX INC
Posizioni attive di Xiaowei Chang
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| AMBRX INC | Direttore/Membro del Consiglio | 01/06/2015 | - |
Hopu Investments Co. Ltd.
 Hopu Investments Co. Ltd. Financial ConglomeratesFinance Hopu Investments Co. Ltd. functions as an investment holding Caymanian company. | Corporate Officer/Principal | 01/01/2014 | - |
Storia della carriera di Xiaowei Chang
Precedenti posizioni note di Xiaowei Chang
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Ambrx Biopharma, Inc.
 Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | Direttore/Membro del Consiglio | 01/06/2015 | 06/10/2023 |
| Independent Dir/Board Member | 01/06/2015 | 06/10/2023 | |
| China International Capital Corp. Ltd. (Private Equity) | Corporate Officer/Principal | 01/01/2011 | 01/01/2014 |
Formazione di Xiaowei Chang
| Tsinghua University | Graduate Degree |
Statistiche
Distribuzione geografica
| Cina | 3 |
| Isole Cayman | 3 |
| Stati Uniti | 2 |
Posizioni
| Director/Board Member | 2 |
| Corporate Officer/Principal | 2 |
| Independent Dir/Board Member | 1 |
Settori
| Health Technology | 3 |
| Finance | 3 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 4 |
|---|---|
Ambrx, Inc.
 Ambrx, Inc. Pharmaceuticals: MajorHealth Technology Ambrx, Inc. engages in discovering and developing of protein therapeutics. It offers non-native amino acids through expanded genetic code to both generate novel bio-therapeutics. The company was founded by Richard DiMarchi, Peter G. Schultz, and Troy E. Wilson on April 15, 2003 and is headquartered in La Jolla, CA. | Health Technology |
Ambrx Biopharma, Inc.
Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | Health Technology |
| China International Capital Corp. Ltd. (Private Equity) | Finance |
Hopu Investments Co. Ltd.
Hopu Investments Co. Ltd. Financial ConglomeratesFinance Hopu Investments Co. Ltd. functions as an investment holding Caymanian company. | Finance |
- Borsa valori
- Insiders
- Xiaowei Chang
- Esperienza